Neuberger Berman Group LLC Blueprint Medicines Corp Transaction History

Neuberger Berman Group LLC

$118 Billion
Q1 2024

A detailed history of Neuberger Berman Group LLC transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Neuberger Berman Group LLC holds 51,308 shares of BPMC stock, worth $5.99 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

51,308

Holding current value

$5.99 Million

% of portfolio

0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $3.75 Million - $5.12 Million	51,308 New	51,308 $4.87 Million
Q4 2023 Feb 09, 2024	SELL	$43.96 - $92.84 $626,913 - $1.32 Million	-14,261 Reduced 25.12%	42,506 $3.92 Million
Q3 2023 Nov 14, 2023	BUY	$46.9 - $66.0 $17,165 - $24,156	366 Added 0.65%	56,767 $2.85 Million
Q2 2023 Aug 11, 2023	BUY	$42.2 - $66.37 $558,095 - $877,743	13,225 Added 30.63%	56,401 $3.56 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $141,855 - $186,800	3,736 Added 9.47%	43,176 $1.94 Million

Q4 2022 Feb 13, 2023	BUY	$41.06 - $66.48 $471,245 - $762,990	11,477 Added 41.04%	39,440 $1.73 Million
Q3 2022 Nov 15, 2022	BUY	$49.93 - $77.7 $1.4 Million - $2.17 Million	27,963 New	27,963 $1.84 Million
Q4 2019 Feb 12, 2020	SELL	$66.73 - $82.59 $834,125 - $1.03 Million	-12,500 Reduced 55.56%	10,000 $801,000
Q3 2019 Nov 13, 2019	SELL	$72.9 - $101.41 $444,690 - $618,601	-6,100 Reduced 21.33%	22,500 $1.65 Million
Q2 2019 Aug 13, 2019	BUY	$73.54 - $97.8 $632,444 - $841,080	8,600 Added 43.0%	28,600 $2.7 Million
Q1 2019 May 13, 2019	BUY	$48.7 - $86.6 $974,000 - $1.73 Million	20,000 New	20,000 $1.6 Million
Q2 2018 Aug 13, 2018	SELL	$60.96 - $101.18 $591,982 - $982,558	-9,711 Closed	0 $0
Q1 2018 May 08, 2018	SELL	$73.28 - $102.95 $21,177 - $29,752	-289 Reduced 2.89%	9,711 $890,000
Q4 2017 Feb 14, 2018	BUY	$62.91 - $88.32 $629,100 - $883,199	10,000	10,000 $754,000

Others Institutions Holding BPMC

# of Institutions

316

Shares Held

60.6M

Call Options Held

634K

Put Options Held

691K

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.98B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Neuberger Berman Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Neuberger Berman Group LLC with notifications on news.

Account

Neuberger Berman Group LLC Blueprint Medicines Corp Transaction History